𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The ubiquitin/proteasome system in Epstein–Barr virus latency and associated malignancies

✍ Scribed by Nico P. Dantuma; Maria G. Masucci


Book ID
114340588
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
276 KB
Volume
13
Category
Article
ISSN
1044-579X

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Latency pattern of Epstein-Barr virus an
✍ Mikio Yoshioka; Hideaki Kikuta; Nobuhisa Ishiguro; Rika Endo; Kunihiko Kobayashi 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB

## Abstract Expression of different panels of latent gene transcripts is controlled by usage of three distinct Epstein‐Barr virus (EBV) nuclear antigen (EBNA) promoters (Wp, Cp, and Qp). EBV‐associated hemophagocytic syndrome, which is often a fatal disease and generally occurs after primary EBV in

Expression of the c-fgr related transcri
✍ Christine Klein; Pierre Busson; Thomas Tursz; Lawrence S. Young; Nancy Raab-Trau 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 French ⚖ 931 KB

The proto-oncogene c-fgr is expressed at high levels in cell lines derived from lymphomas which are infected with Epstein-Barr virus (EBV) (Cheah eta/., 1986). mRNA extracted directly from biopsies of EBV-infected tissues was analyzed on Northern blots to determine if c-fgr is expressed during lymph

Proteasome inhibitors reconstitute the p
✍ Riccardo Gavioli; Simona Vertuani; Maria G. Masucci 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 157 KB

## Abstract EBV‐infected cells and EBV‐associated tumors may evade CTL recognition by defective antigen processing, resulting in poor presentation of CTL epitopes. Since the proteasome is the major source of MHC class I–presented peptides, we analyzed the effect of proteasome inhibitors on the expr